CompletedNot Applicable

Half-normal Saline in Atrial Flutter Ablation

Canada4 participantsStarted 2018-01-01

Plain-language summary

To assess the acute and long-term efficacy of half-normal saline compared to normal saline for irrigation of open-irrigated catheters during catheter ablation for the treatment of cavotricuspid isthmus dependent atrial flutter.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients \> 18 years of age at the time of enrollment * Patients presenting for right sided typical atrial flutter ablation who have a clinical indication to undergo catheter ablation * Fully informed written informed consent by either the subject or subject's legal representative and ability for subject to comply with study responsibilities Exclusion Criteria: * The presence of thrombus within the left atrial appendage * Prior catheter ablation of the cavotricuspid isthmus for right sided atrial flutter * The inability to provide consent or comply with study requirements * A predicted life expectancy of \< 12 months

What they're measuring

Time taken to produce bidirectional block

Timeframe: intraprocedural

Acute recurrence rate < 30 minutes of initial occurrence of bidirectional block

Timeframe: intraprocedural

Freedom from atrial flutter recurrence

Timeframe: 1 year

Trial details

NCT IDNCT04001530

SponsorSunnybrook Health Sciences Centre

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-01-31

View on ClinicalTrials.gov More Atrial Flutter trials